-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

2560 The Actin Bundling Protein L-Plastin Mediates Platelet Force Generation and Thrombosis

Program: Oral and Poster Abstracts
Session: 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Poster II
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Biological Processes, emerging technologies, molecular biology, Technology and Procedures
Sunday, December 10, 2023, 6:00 PM-8:00 PM

Seema Bhatlekar, PhD1*, Shancy Jacob2*, Marina Tistao, PhD1*, Molly Y Mollica, PhD3*, Nicole Rhoads4*, Lili Chen, PhD4*, Bhanu Kanth Manne, PhD2*, Darian Murray, B.S.1*, Siqi Guo1*, Sharon Celeste Morley5*, Jesse W Rowley, PhD2, Matthew T. Rondina, MD6,7, Raymond Adili, MD4, Jose A. Lopez, M.D8 and Li Guo, MD, PhD4,9

1University of Utah, Salt Lake City, UT
2Molecular Medicine Program, University of Utah, Salt Lake City, UT
3University of Maryland, Baltimore County, Baltimore, MD
4Bloodworks Research Institute, Seattle, WA
5Washington University School of Medicine, St Louis, MT
6Department of Internal Medicine and Geriatric Research and Education Clinical Center, George E. Wahlen VAMC, Salt Lake City, UT
7Department of Pathology, University of Utah School of Medicine, University of Utah, Salt Lake City, UT
8University of Washington, Bloodworks Research Institute, Seattle, WA
9Division of Hematology and Oncology, University of Washington, Seattle, WA

Within minutes of activation, platelets dramatically change their shape, forming filopodia and lamellipodia, aggregate with other platelets or different cells, and can increase their surface area up to 4 times. This relies on a dynamic actin cytoskeleton, regulated by many actin binding proteins in a time- and spatial-specific manner. Deficiency or inhibition of several actin binding proteins in platelets have been shown with impaired platelet spreading and reduced thrombosis. Recently, we found that an actin bundling protein, L-plastin, is expressed in platelets. Its function in platelets has not been studied. In megakaryocytes, we showed that L-plastin is responsible for maintaining cytoskeletal stiffness; in this study we sought to determine L-plastin’s role in platelet functions, including thrombosis.

We examined the role of L-plastin in platelets in vivo and ex vivo using L-plastin deficient (Lcp1-/-) male and female mice. First, we used the collagen/epinephrine induced pulmonary embolism (PE) model and found that survival times were significantly shorter in Lcp1-/- mice than in their littermate wildtype (WT) controls (Mean±SEM WT 202±12 sec, Lcp1-/- 139.5±14 sec, P=0.004), suggesting accelerated thrombosis upon L-plastin deficiency in vivo. Second, we examined L-plastin’s role in arterial thrombosis in vivo using the laser-induced cremaster arteriole thrombosis mode. Platelets were labeled with anti-GPIb IgG derivative X488 and the thrombosis formation after laser injury was recorded. Preliminary data indicate that thrombi in Lcp1-/- mice are larger than those in WT mice. Third, we examined L-plastin’s role in platelet adhesion using a microfluidics assay with DiOC6-labelled whole blood. At a shear rate of 200/s, the Lcp1-/- mice had significantly increased platelet adhesion to both collagen and fibrinogen matrices. Fourth, to evaluate the effect of L-plastin on platelet aggregation in vitro, we stimulated washed platelets with 3 different concentrations of thrombin and measured the platelet aggregation (i.e., 0.1, 0.5 and 1 U/mL). When platelets are stimulated with 0.5U/mL or 1U/mL thrombin, platelets from WT and Lcp1-/- mice showed comparable aggregation kinetics. At 0.1U/mL thrombin, however, preliminary data showed increased aggregation in the Lcp1-/- group. The difference between the low and high concentration of thrombin indicates potential regulation of the GPIba mediated actin cytoskeleton rearrangement during platelet aggregation. We next examined under low thrombin concentration, the platelet actin cytoskeleton reorganization and platelet spreading. We seeded washed platelets on a fibrinogen matrix with the presence of thrombin (0.1U/mL). Platelets were then fixed and stained for F-actin and imaged using immunofluorescent confocal microscopy. The spreading area per platelet was calculated using FIJI software. Platelets from Lcp1-/- mice showed significantly increased average membrane area at 30 min (Median WT 689 pixels, Lcp1-/- 866 pixels, P<0.0001). This suggests that the actin rearrangement in platelets upon fibrinogen activation and thrombin stimulation is inhibited by L-plastin. Lastly, we examined whether L-plastin is involved in platelet force generation during the actin reorganization. We used a recently developed “black dot” assay. Briefly, a fluorescent pattern (i.e., black dots) was microcontact printed onto a flexible polydimethylsiloxane substrate and coated with fibrinogen. Platelets were seeded onto the matrix and fixed after 30 min. The contractile forces of individual platelets were measured based on the deformation of the fluorescent micropattern as illustrated in Fig 1A. The contractile force in platelets from Lcp1-/- mice is decreased with altered actin distribution pattern compared to WT mice (Fig 1. Contractile force per platelet, Mean±SEM WT 14.78±0.86nN, Lcp1-/- 12.03±0.67nN, P=0.01).

In summary, we found accelerated thrombosis in Lcp1-/- mice, associated with accelerated platelet adhesion and spreading ex vivo. Mechanistically, our preliminary data suggest this is due to impaired actin bundle formation and decreased platelet contractile force. L-plastin may be unique among actin binding proteins.

Disclosures: No relevant conflicts of interest to declare.

*signifies non-member of ASH